Sanofi Bets Big On IO With Synthorx Buy

Expects Interleukin-2 To Be Foundation Of Future IO-IO Combos

 
• By Kevin Grogan
French flag
France's Sanofi building oncology franchise • Source: Shutterstock

More from Deals

More from Business